Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S. November 16, 2020 Martin Berman-Gorvine Almost two-thirds of participants in clinical trials to support U.S. drug approvals from 2015 to 2019 were located outside the U.S., the FDA’s Center for Drug Evaluation and Research (CDER) said in a new report released last week. Read More
